Significant profits at stake in MS drug patent battle

It is well known that pharmaceutical companies make a great deal of money from their products.  It is also indisputable that they make significant profit from the drugs they sell to treat those of us with chronic illnesses, including multiple sclerosis. There are widespread beliefs that some companies manipulate the system to gain further patent …

Advertisement